# A Study of Brodalumab in Subjects With Axial Spondyloarthritis (axSpA)

> **NCT02985983** · PHASE3 · COMPLETED · sponsor: **Kyowa Kirin Co., Ltd.** · enrollment: 159 (actual)

## Conditions studied

- Axial Spondyloarthritis

## Interventions

- **DRUG:** Brodalumab
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02985983
- **Lead sponsor:** Kyowa Kirin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-07
- **Primary completion:** 2019-09-23
- **Final completion:** 2019-09-23
- **Target enrollment:** 159 (ACTUAL)
- **Last updated:** 2024-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02985983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02985983, "A Study of Brodalumab in Subjects With Axial Spondyloarthritis (axSpA)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02985983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*